Search in:   Search
spacer

Sweden Pharmaceuticals & Healthcare Report Q2 2013

Published by Business Monitor International on Mar 7, 2013 , 98 pages
PDF - Download Now with 3 Quarterly Updates format - Delivered by download


Description
BMI View: We remain of the opinion that the value of the Swedish pharmaceutical market will decline in US dollars over our five-year forecast period to 2017, partly on account of deteriorating external economic environment, with stagnation on the cards in local currency terms. While the latter will nudge into a positive territory over the ten-year forecast period, US growth rates will remain negative, thus discouraging multinational involvement, especially given that patented medicines will continue to be squeezed by factors such as patent expirations and cost-containment strategies.



REPORT TOOLSarrow
Share This Report
Request More Information
Printable Brochure
ORDERINGarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB

PUBLISHERarrow
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.\n\nBMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.
Publisher Details


Privacy Policy | Terms of Use | Sitemap

Copyright © 2012 Fast Market Research, Inc.